+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells



A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells



International Journal of Molecular Medicine 17(2): 323-329



Histone deacetylase inhibitors (HDACIs) can inhibit cell proliferation, induce cell cycle arrest, and stimulate the apoptosis of cancer cells. We investigated the effects of a novel HDACI, Scriptaid, on the Ishikawa endometrial cancer cell line, SK-OV-3 ovarian cancer cell line, and normal human endometrial epithelial cells.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 011698252

Download citation: RISBibTeXText

PMID: 16391833


Related references

M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson's disease. Journal of Neural Transmission. Supplementum: 447-456, 2006

Retraction notice to "M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6- aminonicotinamide treatment" Exp Neurol 176 (2002) 308-321. Experimental Neurology 247: 755-755, 2013

CBFbeta allosterically regulates the Runx1 Runt domain via a dynamic conformational equilibrium. Nature Structural and Molecular Biology 11(9): 901-906, 2004

A natural high-lime silicate liquid more basic than basalt. Journal of Petrology 7(3): 414-420, 1966

Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing. Plos Pathogens 10(4): E1004071, 2014

Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines. Acta Pharmacologica Sinica 28(5): 712-720, 2000

TAGLN suppresses proliferation and invasion, and induces apoptosis of colorectal carcinoma cells. Tumour Biology 34(1): 505-513, 2013

FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells. Oncogene 22(58): 9231-9242, 18 December, 2003

Human endogenous retrovirus-FRD envelope protein (syncytin 2) expression in normal and trisomy 21-affected placenta. Retrovirology 5: 6, 2008

Scribes: Re-writing the story on patient and provider experience. Healthcare 5(3): 95-97, 2017

Histone deacetylase inhibitor givinostat: the small-molecule with promising activity against therapeutically challenging haematological malignancies. Journal of ChemoTherapy 28(4): 247-254, 2016

A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats. Biological Psychiatry 64(11): 974-981, 2008

The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. Oncology Reports 27(1): 10-16, 2012

Histone deacetylase inhibition selectively modulates gene expression through chromatin acetylation. Proceedings of the American Association for Cancer Research Annual Meeting (41): 808, 2000

Histone deacetylase inhibition and progesterone act synergistically to stimulate baboon glycodelin gene expression. Journal of Molecular Endocrinology 38(3-4): 401-407, 2000